to evaluate the appropriate dosage of polyestradiol phosphate ( pep , estradurin ) as single-drug therapy , patients with metastatic prostatic carcinoma were given 80 , 160 or 240 mg pep every 4 weeks for at least 6 months .
C0071554
polyestradiol phosphate
C0687716
estradurin